The level of IL‐6 was found to be increased in patients with DCM, which were involved in affecting myocardial fibrosis, cardiac hypertrophy, and glucose homeostasis during the development of DCM.48, 49, 50. This evidence concerns the gene IL6 and cardiac hypertrophy.